Top Story

Alcon to acquire WaveTec Vision, full rights to ORA System

August 27, 2014

Alcon announced it has entered into an agreement to acquire WaveTec Vision, according to a company press release.

Upon completion of the acquisition, Alcon will gain full rights to the ORA System and plans to immediately begin integration of WaveTec into its surgical business franchise, according to the release.

Allergan requests preliminary injunction against Valeant, Pershing Square

August 27, 2014
Allergan has requested that the U.S. District Court for the Central District of California set an expedited schedule for discovery, as well as a motion for a preliminary…
FDA News

FDA grants labeling extension to class 3 contact lenses, IOLS

August 26, 2014
The U.S. Food and Drug Administration announced on its website that the Center for Devices and Radiological Health has granted a 1-year extension of the Sept. 24, 2014…

Ampio to request FDA for unmasked trial of DME treatment

August 25, 2014
Ampio Pharmaceuticals announced it plans to request that the U.S. Food and Drug Administration allow the company to unmask the OptimEyes 505(b)2 clinical trial, complete…

Blepharitis Management: Current Thinking and Clinical Insights

This activity is sponsored by Bausch + Lomb.

7/25/2014
Blepharitis Management: Current Thinking and Clinical Insights
More »

Bacterial Conjunctivitis Challenge

This activity is sponsored by Sponsored by Bausch + Lomb.

10/28/2013
How much do you know about bacterial conjunctivitis treatment? Each question on this challenge features expert…
More »

Filter By:

Breaking News

Alcon to acquire WaveTec Vision, full rights to ORA System

August 27, 2014
Alcon announced it has entered into an agreement to acquire WaveTec Vision, according to a company press release.Upon completion of the acquisition…

Allergan requests preliminary injunction against Valeant, Pershing Square

August 27, 2014
Allergan has requested that the U.S. District Court for the Central District of California set an expedited schedule for discovery, as well as a…
FDA News

FDA grants labeling extension to class 3 contact lenses, IOLS

August 26, 2014
The U.S. Food and Drug Administration announced on its website that the Center for Devices and Radiological Health has granted a 1-year extension of…

Ampio to request FDA for unmasked trial of DME treatment

August 25, 2014
Ampio Pharmaceuticals announced it plans to request that the U.S. Food and Drug Administration allow the company to unmask the OptimEyes 505(b)2…

Bionic eye system gains financial support in France

August 22, 2014
The French Ministry of Health has approved financial support for a bionic eye treatment, according to a Second Sight Medical Products press…

NovaBay discontinues studies on NVC-422 for viral conjunctivitis

August 21, 2014
NovaBay Pharmaceuticals announced in a press release that its phase 2 clinical study for NVC-422 ophthalmic formulation for patients with adenoviral…

Carl Zeiss Meditec reports 7.3% revenue growth in Q2

August 20, 2014
Carl Zeiss Meditec reported an increase in revenue to €673.7 million, corresponding to a growth of 7.3% after adjusting for exchange rates…

PhysIOL, Carl Zeiss Meditec settle legal dispute over trifocal IOLs

August 19, 2014
PhysIOL and Carl Zeiss Meditec have reached an out-of-court settlement of a legal dispute about patents and utility models for trifocal IOLs…

Valeant extends expiration of offer to acquire Allergan

August 18, 2014
Valeant Pharmaceuticals announced it has delayed the expiration of its exchange offer to acquire all outstanding shares of Allergan to 5 p.m. EST on…
Industry News

Nicox to co-promote latanoprostene bunod with Bausch + Lomb in US

August 15, 2014
Nicox announced its decision to exercise the option to co-promote latanoprostene bunod with Bausch + Lomb in the U.S., according to a company press…
More Headlines »